The new findings of gut-brain interaction reveal TCM's guidance in clinical practice
-
摘要: 心身胃肠病是中西医临床诊治实践中的巨大挑战。“肠脑互动”“漏肠综合征”“肠道微生态”等西医前沿进展部分验证了祖国医学心身同治、天人合一的理念，特别是“五行脏腑”理论。该文追踪西医最新研究成就，以此诠释中医整体医学理念，探讨在心身胃肠疾病的病理病机研究以及临床诊治工作中，如何实现中西医理论融合和手段并施。Abstract: Psychosomatic gastrointestinal disorders(or gut-brain interaction disorder)is a great challenge in the clinical practice.Advances in Western medicine such as "gut-brain interaction", "leaky gut syndrome", and "gut microbiota" have partly verified the philosophy of "mind-body coexistence" and "the unity of nature and human" in the Traditional Chinese Medicine(TCM), especially the theory of "five elements and Zang-fu organs". This paper tracks the latest research achievements of Western medicine, interprets the holistic medical concept of TCM, and discusses how to realize the integration of theories and methods of TCM and western medicine in the case-pathogenesis research and clinical diagnosis and treatment of psychosomatic gastrointestinal disorders.
-
-
[1] Black CJ, Drossman DA, Talley NJ, et al. Functional gastrointestinal disorders: advances in understanding and management[J]. Lancet, 2020, 396(10263): 1664-1674. doi: 10.1016/S0140-6736(20)32115-2
[2] Kaplan GG. "The Global Burden of IBD: from 2015 to 2025"[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(12): 720-727. doi: 10.1038/nrgastro.2015.150
[3] 李军祥, 陈胜良. 脾胃病证的科学内涵与外延[M]. 北京: 中华医学电子音像出版社, 2019.
[4] Nulsen B, LeBrett W, Drossman DA, et al. A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2021, 54(3): 281-291. doi: 10.1111/apt.16467
[5] Mayou R, Kirmayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V[J]. Am J Psychiatry, 2005, 162(5): 847-855. doi: 10.1176/appi.ajp.162.5.847
[6] Weltens N, Iven J, Van Oudenhove L, et al. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation[J]. Ann N Y Acad Sci, 2018, 1428(1): 129-150. doi: 10.1111/nyas.13969
[7] Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans[J]. Gut, 2019, 68(8): 1516-1526. doi: 10.1136/gutjnl-2019-318427
[8] 陈胜良. 中国消化心身健康问题处置专家意见[M]. 北京: 中华医学电子音像出版社, 2015.
[9] Wauters L, Burns G, Ceulemans M, et al. Duodenal inflammation: an emerging target for functional dyspepsia?[J]. Expert Opin Ther Targets, 2020, 24(6): 511-523. doi: 10.1080/14728222.2020.1752181
[10] Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia[J]. Gut, 2020, 69(3): 591-600. doi: 10.1136/gutjnl-2019-318536
[11] Wauters L, Ceulemans M, Frings D, et al. Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia[J]. Gastroenterology, 2021, 160(5): 1521-1531. e9. doi: 10.1053/j.gastro.2020.12.016
[12] Li Q, Wang B, Qiu HY, et al. Chronic Jet Lag Exacerbates Jejunal and Colonic Microenvironment in Mice[J]. Front Cell Infect Microbiol, 2021, 11: 648175. doi: 10.3389/fcimb.2021.648175
[13] Yan XJ, Qiu HY, Luo QQ, et al. Improving Clinician-Patient Communication Alleviates Stigma in Patients With Functional Dyspepsia Receiving Antidepressant Treatment[J]. J Neurogastroenterol Motil, 2022, 28(1): 95-103. doi: 10.5056/jnm20239
[14] Yan XJ, Luo QQ, Qiu HY, et al. The impact of stigma on medication adherence in patients with functional dyspepsia[J]. Neurogastroenterol Motil, 2021, 33(2): e13956.
[15] Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease[J]. Gastroenterology, 2013, 144(1): 36-49. doi: 10.1053/j.gastro.2012.10.003
[16] Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review[J]. JAMA, 2015, 313(9): 949-958. doi: 10.1001/jama.2015.0954
[17] 王博, 陈胜良. 难治性功能性胃肠病中枢神经药物的治疗[J]. 中国实用内科杂志, 2020, 40(2): 100-104. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202002005.htm
[18] Chen SL. A review of drug therapy for functional dyspepsia[J]. J Dig Dis, 2013, 14(12): 623-625. doi: 10.1111/1751-2980.12094
[19] Luo QQ, Chen SL. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis[J]. J Dig Dis, 2017, 18(4): 203-206. doi: 10.1111/1751-2980.12472
[20] Ford AC, Harris LA, Lacy BE, et al. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2018, 48(10): 1044-1060. doi: 10.1111/apt.15001
[21] Lahtinen P, Jalanka J, Hartikainen A, et al. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2020, 51(12): 1321-1331. doi: 10.1111/apt.15740
[22] Sceats LA, Dehghan MS, Rumer KK, et al. Surgery, stomas, and anxiety and depression in inflammatory bowel disease: a retrospective cohort analysis of privately insured patients[J]. Colorectal Dis, 2020, 22(5): 544-553. doi: 10.1111/codi.14905
-
计量
- 文章访问数: 1362
- PDF下载数: 594
- 施引文献: 0
下载: